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Objective: To examine the effects of designation and
volume of neonatal care at the hospital of birth on
mortality and morbidity outcomes in very preterm
infants in a managed clinical network setting.
Design: A retrospective, population-based analysis of
operational clinical data using adjusted logistic
regression and instrumental variables (IV) analyses.
Setting: 165 National Health Service neonatal units in
England contributing data to the National Neonatal
Research Database at the Neonatal Data Analysis Unit
and participating in the Neonatal Economic, Staffing
and Clinical Outcomes Project.
Participants: 20 554 infants born at <33 weeks
completed gestation (17 995 born at 27–32 weeks;
2559 born at <27 weeks), admitted to neonatal care
and either discharged or died, over the period 1
January 2009–31 December 2011.
Intervention: Tertiary designation or high-volume
neonatal care at the hospital of birth.
Outcomes: Neonatal mortality, any in-hospital
mortality, surgery for necrotising enterocolitis, surgery
for retinopathy of prematurity, bronchopulmonary
dysplasia and postmenstrual age at discharge.
Results: Infants born at <33 weeks gestation and
admitted to a high-volume neonatal unit at the hospital
of birth were at reduced odds of neonatal mortality (IV
regression odds ratio (OR) 0.70, 95% CI 0.53 to 0.92)
and any in-hospital mortality (IV regression OR 0.68,
95% CI 0.54 to 0.85). The effect of volume on any in-
hospital mortality was most acute among infants born
at <27 weeks gestation (IV regression OR 0.51, 95% CI
0.33 to 0.79). A negative association between tertiary-
level unit designation and mortality was also observed
with adjusted logistic regression for infants born at
<27 weeks gestation.
Conclusions: High-volume neonatal care provided at
the hospital of birth may protect against in-hospital
mortality in very preterm infants. Future developments of
neonatal services should promote delivery of very preterm
infants at hospitals with high-volume neonatal units.
INTRODUCTION
Intense debate has revolved around the
optimal organisation of neonatal critical care
services. Numerous studies have suggested
that the intensity and volume of neonatal care
at the hospital of birth is negatively correlated
with adverse clinical outcomes, including
mortality.1–11 This has contributed to calls for
centralisation of neonatal services and the
closure of smaller neonatal units.2 11 12
Following a review by the Department of
Health in 2003, perinatal centres in England
were reorganised into managed clinical net-
works (MCN).13 MCNs provide some of the
benefits of centralisation, but also strive to
maintain equity and ease of access to services
by keeping lower care level and lower volume
neonatal units open, with provision for trans-
fer to higher care level or higher volume
units, if required.13 Particular emphasis is
placed on the importance of transferring
women at risk of extremely preterm labour
to tertiary centres before delivery.
Consequently, most networks aim to transfer
women at high risk of delivery at <27 weeks
gestation. We have previously shown that,
Strengths and limitations of this study
▪ A national dataset consisting of the electronic
patient records of a large majority of admissions
to neonatal specialist care in England.
▪ The analysis takes into account observed and
unobserved confounding.
▪ A weakness is that the analysis is unable to dis-
entangle the effects of the neonatal unit at the
place of birth from subsequent transfers to other
neonatal units.
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since the formation of MCNs, the proportion of low-
gestational age infants born in hospitals with higher des-
ignation neonatal units and their transfer rate between
hospitals has increased significantly; however, it remains
unclear what effect this has had on clinical outcomes.14
Studies that have examined the effects of neonatal
unit designation or volume of neonatal care provided at
the hospital of birth have shown that low designation
level or volume is associated with increased rates of mor-
tality,1–10 decreased infection rate,7 increased severe
periventricular haemorrhage11 and increased broncho-
pulmonary dysplasia.7 However, these studies were
almost exclusively conducted in the USA where there is
greater variability in neonatal unit volume—the highest
volume units in the USA are typically much larger than
equivalent units in England—and there are no formal
arrangements for MCNs. Results from similar studies
using data from the UK are limited and based on data
from 1998 to 1999, prior to the formation of MCNs.15 16
We are not aware of any studies that have examined
infant outcomes for neonatal specialist services in MCNs
in relation to unit designation or volume. In addition,
organisation of neonatal care differs between countries
potentially affecting the generalisability of results from
these systems; for example, in Germany neonatal ser-
vices are markedly deregionalised whereas in Finland
and Portugal there is a high degree of regionalisation.17
Our aim in this study was to examine the effects of
designation and volume of neonatal care provided at the
hospital of birth on mortality and morbidity outcomes.
We assess whether organisational factors remain determi-
nants of clinical outcomes despite the goals of neonatal
reorganisation that sought to ensure that vulnerable
infants are not disadvantaged by their place of birth.
METHODS
Data source and study population
For the purpose of this empirical investigation, we
extracted data from the National Neonatal Research
Database (NNRD) for neonatal units participating in the
Neonatal Economic, Staffing and Clinical Outcomes
Project (NESCOP). The NNRD is held by the Neonatal
Data Analysis Unit (NDAU), Imperial College, London,
and was created from patient-level electronic records of
all infants admitted to 168 of 173 neonatal units in
England. NESCOP included 165 centres providing peri-
natal care. On behalf of NESCOP, the Medical Research
Council (MRC) EPICure studies carried out the Unit
Profile Survey (UPS) during 2011, comprising a survey
of English hospitals that provided onsite obstetric and
neonatal services. We extracted records from the NNRD
of all infants born in participating centres at ≤32+6
weeks+days gestation, admitted over the period 1 January
2009–31 December 2011, and who were discharged or
died over the same period. We excluded infants who
only received transitional care (n=5), which was defined
according to English Department of Health’s Healthcare
Resource Group (HRG4) code ‘XA04Z’.18 Gestational
age was determined by ultrasound scan.
Outcomes
We derived the following outcomes from the extracted
data for use in the analyses: 28-day (neonatal) mortality,
any in-hospital mortality, surgery for necrotising entero-
colitis, treatment for retinopathy of prematurity (ROP)
and bronchopulmonary dysplasia (BPD). We defined
BPD as the requirement of supplementary oxygen for at
least 28 days and at 36 weeks postmenstrual age
(PMA).19 We also examined PMA at discharge as a
marker of length of stay; this was defined as the gesta-
tional age at birth plus the length of stay at final dis-
charge from any neonatal unit or death. We defined the
outcome to be one if the PMA at discharge was greater
than 40 weeks and zero otherwise.
Covariates
To determine appropriate covariates, we reviewed previ-
ous prediction models for very preterm infants20 and
selected variables that (1) were significant predictors of
adverse sequelae, (2) were available in our dataset and
of high quality and (3) not confounded by the provision
of neonatal care. The variables we included were: gesta-
tional age at birth, gestational age squared, birthweight
z-score (birth weight standardised by gestational age
week) and the following indicators: whether the mother
received a full or partial course of antenatal steroids,
sex, infant year of birth and whether or not the mother
came from an area within the lowest decile of the Index
of Multiple Deprivation 2007 score.21
Statistical methods
We conducted two separate sets of analyses based on
whether or not infants were admitted to a neonatal unit
at the hospital of birth designated as: (1) a tertiary
centre22 or (2) high volume. For the latter, we defined
volume according to the annual number of care days at
any level of care provided to very preterm infants (≤32+6
weeks gestation). A ‘high-volume’ unit was defined as
one whose volume was in the top quartile of all neonatal
units in the sample. ‘High volume’ was determined by
quartile rather than an absolute care day threshold to
facilitate comparison with other measures of volume in
the sensitivity analyses. A previous study that examined
organisational characteristics of neonatal units also cate-
gorised volume using quartiles.17 Dichotomising by
upper quartile divided the infants between high-volume
and low-volume units in approximately the same propor-
tion as between tertiary-level and non-tertiary-level units.
To aid comparison with other studies, in particular from
the USA, and as a robustness check, ‘high volume’ was
also defined as 100 very low birthweight (VLBW;
<1500 g) admissions of infants born in the same hospital
per annum.
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We first conducted an unadjusted comparison of clin-
ical characteristics and outcomes of infants by unit
characteristics. Second, we estimated an adjusted model
and finally, we conducted an adjusted comparison using
an instrumental variables methodology to account for
unobserved confounding. In the absence of a rando-
mised control trial, instrumental variables methodology
acts as an ex post randomisation and enables us to esti-
mate the ‘causal effects’ of designation and volume of
neonatal care provided at the hospital of birth. The
methodology involves the use of a variable called an
‘instrument’ which, in this context, needs to fulfil two
criteria: (1) it should be strongly correlated with the
characteristics of the neonatal unit at the hospital of
birth and (2) it should be uncorrelated with the out-
comes of interest conditional on observed covariates and
therefore uncorrelated with unobserved confounders.
For the instruments, we used indicators for the desig-
nated level of care of the nearest neonatal unit to the
mother’s residence, an indicator for whether it had sur-
gical facilities, an indicator for whether it was high
volume, the distance to the nearest neonatal unit and
the interactions of either the level of care indicators or
high-volume indicator with distance, giving nine instru-
ments in total. Straight line distance was calculated from
the population-weighted centre of the mother’s lower
super output area to each hospital.23
These instrumental variables fulfil condition (1) if
infants are more likely to be born in the hospital closest
to the mother’s residence. They will also fulfil condition
(2) if the location of the mother’s residence is uncorre-
lated with an infant’s unobserved clinical risk. We tested
for a difference in observed characteristics by level and
volume of the nearest neonatal unit. However, tertiary-
level and high-volume units are more likely to be in
urban areas that are socioeconomically deprived so we
may expect to see more preterm and low birthweight
infants being born in these areas.24 We therefore also
controlled for local deprivation when testing for a differ-
ence in means by nearest neonatal unit characteristics
by estimating a linear regression of the observed variable
of interest on the nearest neonatal unit characteristic
and deprivation indicator, and using an F-test to test the
coefficient on the nearest neonatal unit characteristic
variable.
As the outcomes are all binary logistic regression was
used. In order to employ instrumental variables estima-
tion in this framework, two-stage residual inclusion
(2SRI) was used.25 The 2SRI method is explained in
online supplementary appendix A. The SEs were
adjusted for clustering within units.
Our baseline analyses examined infants born at ≤32+6
weeks gestation. We then conducted analyses on subsets
of infants born at ≤26+6 weeks gestation or at 27+0–32+6
weeks gestation; ≤26+6 weeks gestation is the cut-off used
by perinatal networks for prioritising interunit transfers.
‘Statistical significance’, where discussed, refers to a 5%
significance level in all cases.
Missing data and sensitivity analyses
Infants with missing outcomes data were excluded from
the analyses, while those with missing covariate data
were assigned a zero in the case of binary indicators.
There were no infants with missing continuous covari-
ates. We excluded all infants with any missing data as a
further sensitivity analysis.
Separate sensitivity analyses, using our preferred
method of instrumental variables logistic regression, also
explored the effects of: (1) including unit random
effects in the statistical models; (2) removing infants
who died from analyses of the morbidity and PMA at dis-
charge outcomes and defining a new outcome of any
in-hospital mortality and/or BPD to account for possible
bias caused by infants dying prior to experiencing the
morbidity outcome; (3) redefining high volume as the
top 25% of units in terms of intensive care days provided
to ≤32+6 gestational week infants; (4) redefining high
volume as the top 25% of units in terms of number of
≤32+6 gestational week infants cared for and (5) redefin-
ing high volume as at least 100 VLBW infants born in
and admitted to the neonatal unit in the hospital per
annum.
All analyses were carried out with R V.2.14.2 and Stata
V.11.
RESULTS
In total, data for 20 554 infants born at ≤32+6 weeks ges-
tation over the study period and admitted to a neonatal
unit at the hospital of birth were extracted from the
NNRD, 2559 of whom were born at ≤26+6 weeks gesta-
tion. Table 1 provides descriptive statistics of the samples
analysed.
In the sample, 9466 (46.1%) infants were born in hos-
pitals with a tertiary-level neonatal unit and 9541
(46.4%) were born in hospitals with a high-volume neo-
natal unit. The cut-off for high volume was approxi-
mately 3480 annual care days for infants born at ≤32+6
weeks gestation in each hospital. The total sample of
20 554 infants were born in 165 different hospitals, 44
(26.7%) of which had level 3 neonatal units, 81 (49%)
level 2 neonatal units and 39 (23.6%) level 1 neonatal
units. There were 39 (23.6%) neonatal units classified as
high volume, 30 (78%) of which were designated level 3
units; consequently, 14 of the 44 (31.8%) level 3 desig-
nated units were not classified as high volume. Among
the 20 554 infants, 1892 (9.2%) were born in hospitals
with neonatal units that were classified as high volume
but not tertiary level and 1817 (8.8%) were born in hos-
pitals with neonatal units classified as tertiary level but
not high volume.
‘Standard’ adjusted results
Table 2 presents the estimated adjusted ORs associated
with admission to either tertiary or high-volume neo-
natal care at the hospital of birth.
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The standard logistic regressions did not reveal a statis-
tically significant difference in the OR of mortality for
very preterm infants admitted to tertiary-level care at the
hospital of birth compared with their counterparts
admitted to non-tertiary-level care. However, when con-
sidering only infants born at ≤26+6 weeks gestation, we
found a reduction in the OR of neonatal mortality (OR
0.65, 95% CI 0.46 to 0.91, p=0.012), but not any
in-hospital mortality.
For infants admitted to a high-volume neonatal unit at
the hospital of birth, a reduced OR of neonatal mortality
was observed for those born at ≤32+6 weeks gestation
(OR 0.73, 95% CI 0.56 to 0.95, p=0.018) and at ≤26+6
weeks gestation (OR 0.62, 95% CI 0.44 to 0.87,
p=0.006), but this was not replicated for infants born at
27+0 to 32+6 weeks gestation. Those infants born at ≤26+6
weeks gestation were also at reduced OR of any
in-hospital mortality (0.71, 95% CI 0.52 to 0.97,
p=0.033) and increased OR of BPD (OR 1.59, 95% CI
1.18 to 2.14, p=0.002) compared with their counterparts
admitted to a non-high-volume neonatal unit at the hos-
pital of birth. There were no other statistically significant
differences observed for the morbidity outcomes.
Instrument validity
The instruments were strongly correlated with the
characteristics of the unit at the hospital of birth; 88.4%
of infants whose nearest neonatal unit was designated
level 3 were born in a hospital with a level 3 unit com-
pared with only 22.5% of infants whose nearest neonatal
unit was not designated level 3. Table 3 shows descriptive
statistics for the 20 554 very preterm infants by the
designation and volume of the neonatal unit nearest to
the mother’s place of residence. After correcting for
deprivation, there were no statistically significant differ-
ences in the observed covariates.
Instrumental variables logistic regression
Table 4 shows the estimated ORs using the instrumental
variables logistic regressions. We found no significant dif-
ferences in neonatal mortality between infants admitted
to either tertiary or non-tertiary neonatal care at the hos-
pital of birth. We did find an increased OR of treatment
for ROP for very preterm infants born at 27+0–32+6
weeks gestation born in a hospital with a tertiary-level
unit (OR 2.17, 95% CI 1.06 to 4.47, p=0.035).
In contrast to the effect of tertiary-level care, admis-
sion to a high-volume neonatal unit at the hospital of
birth significantly reduced the OR of neonatal mortality
(OR 0.70, 95% CI 0.53 to 0.92, p=0.011) and any
in-hospital mortality (OR 0.68, 95% CI 0.54 to 0.85,
p=0.001) in very preterm infants. These effects were
most acute among infants born at ≤26+6 weeks gestation.
In terms of morbidity, the only significant effect was
found for BPD (OR 1.78, 95% CI 1.12 to 2.81, p=0.014)
for infants born at ≤26+6 weeks gestation and admitted
to high-volume neonatal care at the hospital of birth.
Sensitivity analyses
The results from the sensitivity analyses are presented in
online supplementary appendix B. There were 1172
(5.7%) infants with missing data for antenatal steroids;
there were no missing values for the other covariates.
The results remained qualitatively similar when all
Table 1 Descriptive statistics for preterm infants born ≤32+6 weeks gestation by neonatal unit characteristic at the hospital
of birth








volume unit p Value†
n (%) 9466 (46.1) 11 088 (54.0) 9541 (46.4) 11 013 (53.6)
Gestation (weeks), mean (SD) 29.2 (2.5) 30.0 (2.1) <0.001 29.3 (2.5) 29.9 (2.2) <0.001
Birth weight (g), mean (SD) 1313.9 (438.7) 1451.9 (404.5) <0.001 1326.6 (436.7) 1441.8 (409.4) <0.001
Received full or partial course of
antenatal steroids
6394 (67.6) 7262 (65.5) 0.002 6330 (66.4) 7326 (66.5) 0.790
Deprivation score bottom 10% 2020 (21.4) 1342 (12.1) <0.001 1730 (18.1) 1632 (14.8) <0.001
Male 5048 (53.3) 5397 (53.4) 0.756 5093 (53.4) 5892 (53.5) 0.863
Neonatal mortality 423 (4.5) 366 (3.3) <0.001 394 (4.1) 395 (3.6) 0.043
Any in-hospital mortality 569 (6.0) 425 (3.8) <0.001 527 (5.5) 467 (4.2) <0.001
BPD‡ 3695 (39.0) 2856 (25.8) <0.001 3548 (37.2) 3003 (27.3) <0.001
Treatment for ROP 226 (2.4) 107 (1.0) <0.001 195 (2.0) 138 (1.3) <0.001
Surgery for NEC 167 (1.8) 123 (1.1) <0.001 163 (1.7) 127 (1.2) 0.001
PMA§ at discharge >40+0 weeks 1292 (13.7) 848 (7.7) <0.001 1237 (13.0) 903 (8.2) <0.001
All values are n (%) unless otherwise stated.
*High volume was defined as being in the top quartile of units by number of care days provided to infants born at ≤32+6 weeks gestation.
†Continuous variables were tested by t test, categorical variables by χ2 test.
‡BPD defined as requirement of supplementary oxygen for at least 28 days postbirth and at 36 weeks postmenstrual age.
§PMA at discharge equal to gestational age at birth plus length of stay in weeks.
BPD, bronchopulmonary dysplasia; NEC, necrotising enterocolitis; PMA, postmenstrual age; ROP, retinopathy of prematurity.
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Table 2 Adjusted ORs for outcomes associated with admission to either tertiary or high-volume neonatal care at the hospital of birth using a ‘standard’ logistic regression
model














Neonatal mortality 0.77 (0.59 to 1.00) 0.65* (0.46 to 0.91) 0.92 (0.69 to 1.22) 0.73* (0.56 to 0.95) 0.62** (0.44 to 0.87) 0.86 (0.65 to 1.14)
Any in-hospital mortality 0.91 (0.72 to 1.15) 0.78 (0.57 to 1.06) 1.06 (0.83 to 1.36) 0.83 (0.65 to 1.05) 0.71* (0.52 to 0.97) 0.96 (0.75 to 1.24)
BPD 1.23** (1.07 to 1.40) 1.50** (1.11 to 2.01) 1.17 (0.99 to 1.39) 1.11 (0.97 to 1.28) 1.59** (1.18 to 2.14) 1.02 (0.86 to 1.22)
Treatment for ROP 1.26 (0.91 to 1.75) 1.09 (0.76 to 1.57) 1.52 (0.91 to 2.55) 0.95 (0.68 to 1.32) 0.81 (0.56 to 1.17) 1.22 (0.71 to 2.09)
Surgery for NEC 1.05 (0.76 to 1.44) 0.89 (0.58 to 1.36) 1.17 (0.80 to 1.70) 1.05 (0.76 to 1.45) 0.94 (0.62 to 1.45) 1.11 (0.76 to 1.61)
PMA at discharge >40 weeks 1.17 (0.97 to 1.41) 1.09 (0.87 to 1.37) 1.19 (0.97 to 1.47) 1.13 (0.94 to 1.37) 1.11 (0.89 to 1.38) 1.11 (0.90 to 1.37)
Values are ORs (95% CI).
Models are adjusted for gestational age, gestational age squared, birthweight z-score, use of antenatal steroids, gender, infant year of birth and deprivation.
*p<0.05, **p<0.01, ***p<0.001.
†High volume was defined as being in the top quartile of units by number of care days provided to infants born at ≤32+6 weeks gestation.
BPD, bronchopulmonary dysplasia; NEC, necrotising enterocolitis; PMA, postmenstrual age; ROP, retinopathy of prematurity.
Table 3 Descriptive statistics for the sample of preterm infants born ≤32+6 weeks gestation by designation of the neonatal unit nearest to maternal place of residence

















n (%) 7167 (34.9) 13 387 (65.1) 7357 (35.8) 13 197 (64.2)
Gestation (weeks), mean (SD) 29.6 (2.4) 29.7 (2.3) 0.040 0.418 29.6 (2.4) 29.6 (2.3) 0.181 0.526
Birth weight (g), mean (SD) 1377.4 (429.2) 1394.2 (424.5) 0.007 0.262 1376.7 (426.7) 1394.8 (425.7) 0.004 0.111
Received full or partial course of antenatal
steroids
4703 (65.6) 8953 (66.9) 0.069 0.584 4749 (64.6) 8907 (67.5) <0.001 0.052
Deprivation score bottom 10% 1751 (24.4) 1611 (12.0) <0.001 NA 1476 (20.1) 1886 (14.3) <0.001 NA
Male 3820 (53.3) 7165 (53.5) 0.761 0.854 3958 (53.8) 7027 (53.3) 0.447 0.378
Birth in hospital with tertiary-level unit 4753 (88.4) 2290 (22.5) <0.001 <0.001 3839 (69.5) 3204 (31.9) <0.001 <0.001
Birth in hospital with high-volume unit 3703 (68.9) 3374 (33.1) <0.001 <0.001 4764 (86.3) 2313 (23.0) <0.001 <0.001
All values are n (%) and are a proportion of the column total unless otherwise stated.
*High volume was defined as being in the top quartile of units by number of care days provided to infants born at ≤32+6 weeks gestation.
†Continuous variables were tested by t test, categorical variables by χ2 test.
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infants with any missing data were excluded from the
analyses (see online supplementary table B1).
The results remained robust to the inclusion of unit
level random effects. We further excluded infants who
died from analyses of the morbidity outcomes. This did
not reveal any evidence of differences in the ORs except
for the OR of treatment for ROP for infants admitted to
tertiary-level care at the hospital of birth (OR 1.96, 95%
CI 1.15 to 3.32, p=0.013; see online supplementary table
B2). No evidence of an effect for the outcome defined
as any in-hospital mortality and/or BPD was observed
(see online supplementary table B2). Three alternative
measures of volume were also used. In these sensitivity
analyses, the OR of any in-hospital mortality remained
significantly lower for very preterm infants admitted to a
high-volume unit at the hospital of birth (see online sup-
plementary tables B3 and B4). Only eight hospitals
(4.8%) met the criteria of at least 100 VLBW infants per
annum in any of the study years so that only a small pro-
portion (6.5%) of the sample was inborn and admitted
to these units. There is therefore imprecision around
these results with wide CIs; among these infants, the OR
of any in-hospital mortality was significantly lower but
not statistically significant (see online supplementary
table B4).
DISCUSSION
We examined the effects of designation and volume of
neonatal care provided at the hospital of birth on mor-
tality and morbidity outcomes for very preterm infants
in England. Our key finding was a consistent reduction
in the OR of mortality for very preterm infants admitted
to high-volume neonatal units. We examined infants
born at ≤26+6 weeks gestation and those born at 27+6–
32+6 weeks gestation separately to reflect transfer policies
and found a statistically significant reduction in the OR
of mortality in the former group only. Furthermore, we
found differences in the OR of mortality outcomes
between standard logistic regressions and our preferred
instrumental variables approach. The standard logistic
regressions were generally found to underestimate the
beneficial effects of high-volume care on mortality out-
comes. This was expected given the aim of MCNs to
transfer high-risk infants to high-volume and designation
units. With regards to morbidity outcomes, treatment for
ROP was the only morbidity for which a statistically sig-
nificant effect was observed across analyses. We found
that infants born at 27+6–32+6 weeks gestation in hospi-
tals with tertiary-level units were at increased OR of
receiving treatment for ROP; however, only a very small
number of these infants received treatment for ROP
(86/17 995; 0.5%), suggesting the observed difference
may not be clinically significant.
Our preferred instrumental variables methodology, in
the absence of a randomised assignment of infants to
units, enabled us to estimate the causal effects of desig-
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hospital of birth using observational data. This approach
has been widely applied in other healthcare evalua-
tions.26 However, we can only identify one previous
application of this methodology to the evaluation of
perinatal outcomes.7 Our findings agree with the find-
ings of a US-based study that examined the separate
effects of level and volume of neonatal care.4 We also
found a reduction in the OR of mortality when analysing
the annual number of VLBW admissions of inborn
infants—a measure frequently used in US studies of this
nature.2
We acknowledge limitations to our study. First, instru-
mental variables methodology only identifies the effect
of an intervention or treatment for those individuals
whose assignment to treatment is altered by the instru-
mental variable.27 We do not know the effects for infants
who would always be born in hospitals with a high-level
or high-volume neonatal unit despite the location of the
mother’s residence (see online supplementary appendix
A). Nevertheless, we demonstrated the validity of our
instruments in meeting the required assumptions.
Importantly, the assumptions required for an instrumen-
tal variables methodology are weaker than those
required to support a ‘standard’ analysis, which requires
that infants are randomly assigned to hospitals of birth;
otherwise the estimated ORs will be biased. Second, due
to data limitations we cannot control for the effects of
care and risk of death in the delivery suite at the hospital
of birth. However, high-volume delivery units have been
shown to be associated with a reduced risk of neonatal
mortality.28 29 Since high-volume delivery units are often
found in hospitals with high-volume neonatal care this
would lead us to suspect that our analyses underestimate
the benefits of birth in hospitals with high-volume neo-
natal care.
Third, we are unable to disentangle the effects of the
unit at the place of birth and subsequent transfers on
final outcomes. We therefore cannot assess whether
increasing the provision of transfers attenuates the
increased OR of mortality associated with birth in hospi-
tals without high-volume neonatal care. While identifica-
tion of acute neonatal transfers was possible from our
data, identifying the effects of transfer on outcomes pre-
sents a number of difficult statistical issues. However, we
expect that, if transfers to high-volume units reduce the
OR of mortality, our effects presented in this paper
underestimate the benefit of birth in a hospital with
high-level or high-volume neonatal care (see online sup-
plementary appendix A for an extended discussion),
although neonatal transport itself may have negative
effects on infant health outcomes.30 31 A final limitation
is that a small number of neonatal units in England
(n=8) across MCNs do not contribute data to the NNRD
and/or participate in NESCOP. The effect of also includ-
ing data from these units on outcomes remains a topic
for future enquiry.
An intervention that increases the proportion of very
preterm infants born in hospitals with high-volume
neonatal units may involve increasing the proportion of
in utero transfers. Transfers of women prior to delivery
are generally preferable because they are believed to be
safer and less expensive than postnatal transfers of vul-
nerable infants.32 However, a study in 2009 showed that
almost one-half of all in utero transfer requests to the
London Ambulance Service were unsuccessful for non-
clinical reasons.33 Furthermore, studies from other coun-
tries, including Portugal, Finland and the USA, have
shown that in more regionalised systems as many as 90–
95% of very preterm or VLBW infants are born in hospi-
tals with tertiary designation neonatal units.10 34 35 The
effects of transfers within different organisational struc-
tures for neonatal care remains an important area for
future research especially as the new English
Operational Delivery Networks will supersede the peri-
natal MCNs as part of the changes following the Health
and Social Care Act (2012).36
In conclusion, instrumental variables methodology did
not reveal evidence of a difference in mortality out-
comes between very preterm infants admitted to either
tertiary or non-tertiary neonatal care at the hospital of
birth. However, we do provide evidence of reduced OR
of mortality for very preterm infants admitted to high-
volume neonatal units at delivery hospitals. The effect of
volume on neonatal outcomes is an important consider-
ation for policy makers deciding the optimal organisa-
tion of neonatal specialist services.
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